Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Neumora Therapeutics, Inc.

1.85
0.0000
Post-market: 1.900.0500+2.70%19:19 EDT
Volume:1.36M
Turnover:2.59M
Market Cap:342.78M
PE:-1.39
High:1.98
Open:1.86
Low:1.83
Close:1.85
52wk High:3.65
52wk Low:0.6581
Shares:185.28M
Float Shares:108.00M
Volume Ratio:1.27
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3279
EPS(LYR):-1.4501
ROE:-121.21%
ROA:-58.11%
PB:3.30
PE(LYR):-1.28

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
Neumora Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
96
Office Location:
260 Arsenal Place,Suite 1,Watertown,Massachusetts,United States
Website:
http://www.neumoratx.com
Zip Code:
02472
Phone:
857 760 0900
Fax:
- -
Introduction:
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Directors

Name
Position
Henry O. Gosebruch
President, Chief Executive Officer and Director
Paul L. Berns
Executive Chairman
Alaa Halawa
Director
David Piacquad
Director
Kristina Burow
Director
Matthew Fust
Director
Maykin Ho
Director

Shareholders

Name
Position
Henry O. Gosebruch
President, Chief Executive Officer and Director
Carol Suh
Chief Operating Officer
Joshua Pinto
Chief Financial Officer
Daljit Singh Aurora
Chief Strategy Officer
Lori Houle
Chief Quality Officer
Maryjo Chamberlain Tharp
Chief Business Officer
Michael Gold
Chief Medical Officer
Nicholas Brandon
Chief Scientific Officer
Paul L. Berns
Executive Chairman
Raj Manchanda
Chief Technical Operations Officer
Robert Lenz
Head of Research and Development